← back to search

Ido Amit

Weizmann Institute of Science · IL
Area of research
Immunology · Genetics
Research interest
Research interests include Immune cells in cancer, Immune Cell Function and Interaction, Diabetes and associated disorders, and Single-cell and spatial transcriptomics.
h-index
106
citations
102,537
works
453
NIH funding
primary concept
Biology
email

Recent publications

Peripheral nervous system microglia-like cells regulate neuronal soma size throughout evolution
Cell 2025cited by 32position: middledoi
ZEB2 is a master switch controlling the tumor-associated macrophage program
Cancer Cell 2025cited by 29position: lastdoi
Septal LYVE1 <sup>+</sup> macrophages control adipocyte stem cell adipogenic potential
Science 2025cited by 20position: middledoi
Dissection of the immune landscape in psoriatic arthritis defines immunoproteasome up-regulation in treatment resistance
Science Immunology 2025cited by 4position: lastdoi
Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored Immunotherapy
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 0position: middledoi
Defining myeloid-derived suppressor cells
Nature reviews. Immunology 2024cited by 45position: middledoi
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols
Nature Cancer 2024cited by 29position: lastdoi
The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects
Immunity 2024cited by 27position: middledoi
The commitment of the human cell atlas to humanity
Nature Communications 2024cited by 18position: firstdoi
An immune cell atlas reveals the dynamics of human macrophage specification during prenatal development
Cell 2023cited by 133position: middledoi
The transcriptional and regulatory identity of erythropoietin producing cells
Nature Medicine 2023cited by 60position: lastdoi
Single‐cell biology: what does the future hold?
Molecular Systems Biology 2023cited by 26position: middledoi
Regulation of lymphoid-myeloid lineage bias through regnase-1/3-mediated control of Nfkbiz
Blood 2023cited by 14position: middledoi
Microglia states and nomenclature: A field at its crossroads
Neuron 2022cited by 1,824position: middledoi
Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration
Immunity 2022cited by 349position: middledoi
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis
Nature Cancer 2022cited by 221position: middledoi
LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma
Cell 2022cited by 149position: lastdoi
Early antitumor activity of oral Langerhans cells is compromised by a carcinogen
Proceedings of the National Academy of Sciences 2022cited by 22position: middledoi
Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsuficiency
Haematologica 2022cited by 6position: middledoi
Publisher Correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
Nature Medicine 2022cited by 5position: lastdoi
XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
Nature Medicine 2021cited by 199position: lastdoi
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Blood 2021cited by 26position: middledoi
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis
Cell Death and Differentiation 2021cited by 22position: middledoi
Single-cell analysis of regions of interest (SCARI) using a photosensitive tag
Nature Chemical Biology 2021cited by 18position: middledoi
NF-κB activity during pancreas development regulates adult β-cell mass by modulating neonatal β-cell proliferation and apoptosis
Cell Death Discovery 2021cited by 11position: middledoi
Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine
Nature 2021cited by 10position: middledoi
MYCN mediates cysteine addiction and sensitizes to ferroptosis
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 2position: middledoi
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
Cell 2020cited by 917position: middledoi
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
Cell Research 2020cited by 477position: middledoi
Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome
Nature Cancer 2020cited by 348position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Eyal David · Weizmann Institute of Science20 papers (2014–2025)Hadas Keren‐Shaul · Weizmann Institute of Science9 papers (2014–2021)Amir Giladi · Hubrecht Institute for Developmental Biology and Stem Cell Research9 papers (2015–2023)Diego Adhemar Jaitin · Weizmann Institute of Science8 papers (2013–2024)Alexander Mildner · University of Turku6 papers (2014–2020)Assaf Weiner · Weizmann Institute of Science6 papers (2014–2025)Steffen Jung · UK Dementia Research Institute6 papers (2014–2020)Ronnie Blecher‐Gonen · National Institutes of Health5 papers (2013–2025)Deborah R. Winter · Northwestern University5 papers (2014–2017) · 5 papers (2015–2024)Aviv Regev · Moscow Institute of Thermal Technology5 papers (2012–2017)Shalev Itzkovitz · Massachusetts Institute of Technology5 papers (2017–2023)Nir Hacohen · Broad Institute4 papers (2012–2014)Simon Yona · Hebrew University of Jerusalem4 papers (2017–2022)Mor Zada · Weizmann Institute of Science4 papers (2018–2025) · 4 papers (2015–2020)Nir Friedman · Hebrew University of Jerusalem4 papers (2014–2017)Andreas Trumpp · TRUMPF (Germany)4 papers (2015–2018)Hanjie Li · National University of Singapore4 papers (2020–2024)Hagit Shapiro · Weizmann Institute of Science3 papers (2015–2020)